Search Results - Lance Kates
- Showing 1 - 3 results of 3
-
1
787 AB598, a CD39 inhibitory antibody, promotes immune-mediated tumor control by Christine Bowman, Lance Kates, Amy E Anderson, Julie Clor, Ke Jin, Kaustubh Parashar, Yihong Guan, Sam Schwager, Priyanka Talukdar, Ritu Kushwaha, Janine Kline, Ester Fernandez-Salas
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal by Valeria Yartseva, Leonard D. Goldstein, Julia Rodman, Lance Kates, Mark Z. Chen, Ying-Jiun J. Chen, Oded Foreman, Christian W. Siebel, Zora Modrusan, Andrew S. Peterson, Ana Jovičić
Published in Cell Reports (2020-02-01)Get full text
Article -
3
689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action by Felix Chu, Michael Harbell, Amy Manning-Bog, Alexander Scholz, Ngan Nguyen, Norman Greenberg, William Robinson, Daniel Emerling, Tito Serafini, Wei Cao, Yvonne Leung, Nikhil Vad, Anne Ye, Daniel Santos, Cathrin Czupalla, John Vivian, Carlene Williams, Judevin Sapugay, Shaun Lippow, Chantia Carroll, Lance Kates, Benjamin Haugen, Gary Bolton, Mark Armanini, Iraz Aydin, Mark Whidden, Mauricio Velasco-Delgado, Erin Wechsler
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article
